首页 | 本学科首页   官方微博 | 高级检索  
     


Beta-cell death and dysfunction drives hyperglycaemia in organ donors
Authors:Iestyn M. Shapey PhD  Angela Summers BSc   James O'Sullivan BSc  Catherine Fullwood PhD  Neil A. Hanley MBChB  John Casey MBChB  Shareen Forbes MBChB  Miranda Rosenthal PhD  Paul R. V. Johnson MBChB  Pratik Choudhary MBBS  James Bushnell MD  James A. M. Shaw MBChB  Daniel Neiman PhD  Ruth Shemer PhD  Benjamin Glaser MD  Yuval Dor PhD  Titus Augustine MS  Martin K. Rutter MD  David van Dellen MD
Affiliation:1. Faculty of Medicine, Biology and Health, University of Manchester, Manchester, UK;2. Faculty of Medicine, Biology and Health, University of Manchester, Manchester, UK

Department of Renal and Pancreatic Transplantation, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK;3. Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK;4. Faculty of Medicine, Biology and Health, University of Manchester, Manchester, UK

Department of Research and Innovation (medical statistics), Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK;5. Transplant Unit, Royal Infirmary of Edinburgh, Edinburgh, UK;6. Transplant Unit, Royal Infirmary of Edinburgh, Edinburgh, UK

Endocrinology Unit, University of Edinburgh, Edinburgh, UK;7. Diabetes Unit, Royal Free Hospital, London, UK;8. Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK;9. Diabetes Research Group, King's College London, London, UK;10. Richard Bright Renal Unit, Southmead Hospital, Bristol, UK;11. Institute of Cellular Medicine, Newcastle University, Newcastle, UK;12. Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel;13. Department of Endocrinology and Metabolism, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel;14. Faculty of Medicine, Biology and Health, University of Manchester, Manchester, UK

Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK

Abstract:

Background

Donor hyperglycaemia following brain death has been attributed to reversible insulin resistance. However, our islet and pancreas transplant data suggest that other mechanisms may be predominant. We aimed to determine the relationships between donor insulin use and markers of beta-cell death and beta-cell function in pancreas donors after brain death.

Methods

In pancreas donors after brain death, we compared clinical and biochemical data in ‘insulin-treated’ and ‘not insulin-treated donors’ (IT vs. not-IT). We measured plasma glucose, C-peptide and levels of circulating unmethylated insulin gene promoter cell-free DNA (INS-cfDNA) and microRNA-375 (miR-375), as measures of beta-cell death. Relationships between markers of beta-cell death and islet isolation outcomes and post-transplant function were also evaluated.

Results

Of 92 pancreas donors, 40 (43%) required insulin. Glycaemic control and beta-cell function were significantly poorer in IT donors versus not-IT donors [median (IQR) peak glucose: 8 (7-11) vs. 6 (6-8) mmol/L, p = .016; C-peptide: 3280 (3159-3386) vs. 3195 (2868-3386) pmol/L, p = .046]. IT donors had significantly higher levels of INS-cfDNA [35 (18-52) vs. 30 (8-51) copies/ml, p = .035] and miR-375 [1.050 (0.19-1.95) vs. 0.73 (0.32-1.10) copies/nl, p = .05]. Circulating donor miR-375 was highly predictive of recipient islet graft failure at 3 months [adjusted receiver operator curve (SE) = 0.813 (0.149)].

Conclusions

In pancreas donors, hyperglycaemia requiring IT is strongly associated with beta-cell death. This provides an explanation for the relationship of donor IT with post-transplant beta-cell dysfunction in transplant recipients.
Keywords:beta-cell death  glycaemic control  hyperglycaemia  insulin  islet  organ donor  pancreas  transplant
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号